Jane Wasman, a director at SELLAS Life Sciences Group, Inc. ($SLS), made one open market purchase of company shares in the last year, totaling $33,800. Her most recent buy occurred on May 30, 2025. This places her 3,351st out of 4,983 insiders by purchase value, compared to an average of about $1.46 million per buyer and 3.3 transactions. She reported no open market sales in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 7, 2026 | SELLAS Life Sciences Group, Inc. | $SLS | Wasman Jane | Director | A | Common Stock | 50000 | $0.00 | 92,900.0000 | 142,442,239 | 116.55% | 0.04% |
| May 30, 2025 | SELLAS Life Sciences Group, Inc. | $SLS | Wasman Jane | Director | P | Common Stock | 20000 | $1.69 | 30,400.0000 | 90,846,692 | 192.31% | 0.02% |
| May 23, 2025 | RIGEL PHARMACEUTICALS INC | $RIGL | Wasman Jane | Not found | A | Common Stock | 2500 | $0.00 | 12,500.0000 | 18,169,000 | 25.00% | 0.01% |
| May 23, 2025 | RIGEL PHARMACEUTICALS INC | $RIGL | Wasman Jane | Not found | A | Stock Option (Right to Buy) | 3000 | $0.00 | 3,000.0000 | 18,169,000 | 9999.99% | 0.02% |
| Jan. 10, 2025 | SELLAS Life Sciences Group, Inc. | $SLS | Wasman Jane | Director | A | Stock Option (Right to Buy) | 18500 | $0.00 | 18,500.0000 | 0 | 9999.99% | 0.00% |
| Jan. 10, 2025 | SELLAS Life Sciences Group, Inc. | $SLS | Wasman Jane | Director | A | Common Stock | 12500 | $0.00 | 22,900.0000 | 0 | 120.19% | 0.00% |
| May 25, 2024 | RIGEL PHARMACEUTICALS INC | $RIGL | Wasman Jane | Not found | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 17,520,000 | 9999.99% | 0.17% |
| May 25, 2024 | RIGEL PHARMACEUTICALS INC | $RIGL | Wasman Jane | Not found | A | Common Stock | 25000 | $0.00 | 100,000.0000 | 17,520,000 | 33.33% | 0.14% |
| Jan. 22, 2024 | SELLAS Life Sciences Group, Inc. | $SLS | Wasman Jane | Director | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 22, 2024 | SELLAS Life Sciences Group, Inc. | $SLS | Wasman Jane | Director | A | Common Stock | 6000 | $0.00 | 10,400.0000 | 0 | 136.36% | 0.00% |
| May 26, 2023 | RIGEL PHARMACEUTICALS INC | $RIGL | Wasman Jane | Not found | A | Common Stock | 25000 | $0.00 | 75,000.0000 | 173,568,000 | 50.00% | 0.01% |
| May 26, 2023 | RIGEL PHARMACEUTICALS INC | $RIGL | Wasman Jane | Not found | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 173,568,000 | 9999.99% | 0.02% |
| Feb. 2, 2023 | SELLAS Life Sciences Group, Inc. | $SLS | Wasman Jane | Director | A | Common Stock | 2500 | $0.00 | 4,400.0000 | 0 | 131.58% | 0.00% |
| Feb. 2, 2023 | SELLAS Life Sciences Group, Inc. | $SLS | Wasman Jane | Director | A | Stock Option (Right to Buy) | 9500 | $0.00 | 9,500.0000 | 0 | 9999.99% | 0.00% |